Acasti Pharma Inc.
ACST
Classement en actions
#29743
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Prix de l'action
$0.4256834
Dernière synchronisation: 2023-03-27
Capitalisation boursière
$18.99M
Changement (1 jour)
3.08%
Changement (1 an)
-87.02%
Pays
CA
Échange Acasti Pharma Inc. (ACST)
Catégorie
Healthcare
Ratio P/B pour Acasti Pharma Inc. (ACST)
Ratio P/B au October 2026 TTM : 1.21
Selon les derniers rapports financiers et le cours de l'action de Acasti Pharma Inc., le ratio cours/valeur comptable actuel (TTM) est 1.21. À la fin de 2024, le ratio P/B était de 0.36.
Historique du ratio P/B pour Acasti Pharma Inc. de 2010 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 1.21 | 194.44% |
| 2025 | 0.41 | 14.12% |
| 2024 | 0.36 | 10.08% |
| 2023 | 0.33 | 92.91% |
| 2022 | 0.17 | 27.77% |
| 2021 | 0.13 | -67.27% |
| 2020 | 0.41 | -0.78% |
| 2019 | 0.41 | 85.32% |
| 2018 | 0.22 | 0.00% |
| 2017 | 0.00 | -100.00% |
| 2016 | 0.05 | 43.77% |
| 2015 | 0.03 | 59.69% |
| 2014 | 0.02 | -60.40% |
| 2013 | 0.05 | 72.47% |
| 2012 | 0.03 | -46.46% |
| 2011 | 0.05 | 52.71% |
| 2010 | 0.04 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | 417.81% |
US
|
|
| 13.2547 | 997.97% |
US
|
|
| 4.208 | 248.58% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 412.13% |
NL
|
